Vivimed Labs receives EIR from USFDA for Mexico facility

New Delhi: Drug firm Vivimed Labs has recently received an establishment inspection report (EIR) from the US health regulator for its Mexico manufacturing facility after an inspection.

“The company’s API manufacturing facility located in CUERNAVACA, Mexico was recently inspected by the United States Food and Drug Administration (USFDA) in compliance with their requirements,” Vivimed Labs said in a BSE filing.

“The inspection was successful and company obtained EIR. This was a routine inspection by the USFDA,” it added.

Vivimed Labs Limited is an India-based global supplier of speciality chemicals and pharmaceuticals. Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics.

Read Also: Vivimed Labs to acquire Hungary-based Soneas

The following two tabs change content below.

• Bio
• Latest Posts

MD Team

At Medical Dialogues, we are a team of young professionals strongly advocating of the transparency in the medical sector through the free flow of medical information, health and medical news. MD Team covers a variety of news related to the healthcare, pharma and medical device industry in India. Our team can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Latest posts by MD Team (see all)

• Japan: Victims of forced sterilisation to get compensation, apology - April 25, 2019
• Trump sets speech on opioid fight after drug distributor, executives face criminal charges - April 25, 2019
• Landmark campaign: Malawi rolls out first licensed malaria vaccine - April 24, 2019